Historical record - last NADAC effective date: 4/1/2022

Product Information

MUCINEX FAST-MAX CHEST-CONGEST is a brand product labeled by RB Health (US) LLC, priced at $0.0606 per ML under NDC 63824053766. Its NADAC has been published 19 times since Feb 23, 2022.

The High Outlier badge above means this manufacturer's average price in the Guaifenesin market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

MUCINEX FAST-MAX CHEST-CONGEST

Guaifenesin
$0.0606per ML
High Outlier
OTC

Strength

400 mg/20mL

Manufacturer

RB Health (US) LLC

NDC

63824053766

Classification

Brand

Dosage Form

SOLUTION

Route

ORAL

Effective Date

4/1/2022

Active Ingredients

GUAIFENESIN

Approval Type

OTC MONOGRAPH DRUG

FDA Application

M012

On Market Since

6/1/2020

Pharmacological Classes

Decreased Respiratory Secretion Viscosity
Expectorant
Increased Respiratory Secretions

Price Statistics

The NADAC for MUCINEX FAST-MAX CHEST-CONGEST has been published 19 times since Feb 23, 2022, and over the history we have for it it has risen 16.7%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0606 per ML
All-time high$0.0606 (Jun 29, 2022)
All-time low$0.0520 (Feb 23, 2022)
Median price$0.0606
Average price$0.0579
Largest weekly change+16.7% (Apr 6, 2022)
Weeks tracked19
Tracking sinceFeb 23, 2022

Price History

1W

N/A

1M

N/A

3M

N/A

6M

N/A

1Y

N/A

3Y

N/A

5Y

N/A

All

+16.7%

Last surveyed Jun 29, 2022 — this NDC no longer appears in the current weekly NADAC file.

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Guaifenesin market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Frequently asked questions

What is the NADAC price of MUCINEX FAST-MAX CHEST-CONGEST?

The current National Average Drug Acquisition Cost (NADAC) for MUCINEX FAST-MAX CHEST-CONGEST, manufactured by RB Health (US) LLC, is $0.0606 per ML (NDC 63824053766), effective Jun 29, 2022.

How has the price of MUCINEX FAST-MAX CHEST-CONGEST changed over time?

Over the history we have for it, the NADAC for MUCINEX FAST-MAX CHEST-CONGEST has risen 16.7%. It has been tracked across 19 weekly CMS publications since Feb 23, 2022.

What are the highest and lowest recorded NADAC prices for MUCINEX FAST-MAX CHEST-CONGEST?

Since Feb 23, 2022, the NADAC for MUCINEX FAST-MAX CHEST-CONGEST has ranged from a low of $0.0520 (Feb 23, 2022) to a high of $0.0606 (Jun 29, 2022), with a median of $0.0606 per ML.

Are there cheaper alternatives to MUCINEX FAST-MAX CHEST-CONGEST?

No other NADAC-published product currently shares the active ingredient and strength of MUCINEX FAST-MAX CHEST-CONGEST in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures MUCINEX FAST-MAX CHEST-CONGEST?

MUCINEX FAST-MAX CHEST-CONGEST (NDC 63824053766) is labeled by RB Health (US) LLC, and CMS classifies it as a brand product.